Is Coral Labs. overvalued or undervalued?
As of November 3, 2025, Coral Labs. is considered very attractive due to its undervalued status, highlighted by a PE Ratio of 9.59 and strong growth potential indicated by a PEG Ratio of 0.00, despite recent stock performance lagging behind the Sensex.
As of 3 November 2025, Coral Labs. has moved from an attractive to a very attractive valuation grade. The company appears to be undervalued, given its compelling financial ratios, including a PE Ratio of 9.59, an EV to EBITDA of 4.15, and a Price to Book Value of 0.88. These figures suggest that Coral Labs. is trading at a significant discount compared to its peers in the pharmaceuticals and biotechnology sector.In comparison, Sun Pharma. Inds. is deemed expensive with a PE Ratio of 35.62, while Cipla is rated attractive with a PE Ratio of 22.44. The PEG Ratio for Coral Labs. stands at 0.00, indicating strong growth potential relative to its price. Despite recent stock performance lagging behind the Sensex, particularly in the year-to-date and one-year periods, the underlying valuation metrics suggest that Coral Labs. presents a favorable investment opportunity.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
